Outcomes of Laparoscopic Keyhole Surgery (TAPP) for Recurrent Inguinal Hernia

Clinical Outcomes of Laparoscopic Transabdominal Preperitoneal (TAPP) Approach for Recurrent Inguinal Hernia

The goal of this clinical trial is to learn if a laparoscopic surgery called Transabdominal Preperitoneal (TAPP) repair is safe and works well for adults with a recurrent inguinal hernia (a groin hernia that has returned after a previous operation).

The main questions it aims to answer are:

Does the TAPP technique lower the number of complications after surgery? How well do participants recover during the early postoperative period and long-term follow-up? Fixing a hernia that has returned is hard because of old scar tissue. In this study, researchers will use the TAPP technique to work through a different layer of tissue to provide a stronger repair.

Participants will:

Undergo the TAPP laparoscopic surgery for their recurrent hernia. Visit the clinic for close health monitoring shortly after surgery. Complete regular follow-up checkups to track their long-term recovery.

Study Overview

• Status: Recruiting
• Conditions: Recurrant Inguinal Hernia
• Intervention / Treatment: Procedure: Laparoscopic Transabdominal Preperitoneal (TAPP) Repair

• Study Type: Interventional
• Enrollment (Estimated): 10
• Phase: Not Applicable

Contacts and Locations

• Study Contact: Name: marwa Saber, Resident; Phone Number: 01017659722; Email: marwaelkholy93@gmail.com

Study Locations

• Egypt
  • Sohag, Egypt
    • Recruiting
    • Faculty of medicine
    • Contact: marwa elkholy, Resident; Phone Number: 01017659722; Email: marwaelkholy93@gmail.com

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Child; Adult; Older Adult
• Accepts Healthy Volunteers: No

Description

Inclusion Criteria:

• Adult patients. Patients diagnosed with recurrent inguinal hernia. Patients fit for general anesthesia. Patients who provide informed consent.

Exclusion Criteria:

• Non recurrent inguinal hernia Patients with complicated inguinal hernia. Patients unfit for general anesthesia. Patients refusing participation in the study.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: N/A
• Interventional Model: Single Group Assignment
• Masking: None (Open Label)

Number of Arms

1

Arms and Interventions

Participant Group / Arm

Intervention / Treatment

Experimental: Laparoscopic TAPP Repair; Patients with recurrent inguinal hernia who will undergo laparoscopic transabdominal preperitoneal (TAPP) repair using a synthetic mesh.

Procedure: Laparoscopic Transabdominal Preperitoneal (TAPP) Repair; The surgical procedure will be performed under general anesthesia. Standard laparoscopic instruments will be used to access the peritoneal cavity. The peritoneum over the recurrent inguinal hernia site will be incised to enter the preperitoneal space. After reduction of the hernia sac and clearing of post-operative adhesions, a synthetic mesh will be placed to cover the hernia defects. The mesh will be secured if necessary, and the peritoneal flap will be closed using sutures or tacks.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Feasibility and Technical Success of Laparoscopic TAPP	Evaluation of the feasibility of the TAPP approach in recurrent inguinal hernias, measured by the rate of successful laparoscopic completion without the need for intraoperative conversion to open surgery due to severe scar tissue or adhesions.	During the intraoperative procedure (Day of surgery)

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Post-operative Pain	Assessment of pain severity using the Visual Analog Scale (VAS), which ranges from 0 (no pain) to 10 (worst possible pain).	At 24 hours, 1 week, and 1 month post-operatively
Hernia Recurrence	The percentage of patients who experience another clinical return of the inguinal hernia after the TAPP repair. Recurrence will be detected through physical examination during follow-up, and confirmed by groin ultrasound or CT scan if a hernia is clinically suspected.	4 months
Operative Time	The total duration of the surgical procedure calculated in minutes from the skin incision to the final closure	During the surgical procedure (Day of surgery)
Length of Hospital Stay	The total number of hours or days from the end of the surgery until the patient is officially discharged from the hospital.	From the day of surgery up to hospital discharge (typically 1-2 days)
Incidence of Post-operative Complications	Detection of any early complications like seroma, hematoma, or wound infection.	Up to 4 months post-operatively
Incidence of Intraoperative Complications	The percentage of patients experiencing any surgical complications during the operation, such as urinary bladder injury, bowel injury, or major vascular bleeding	During the surgical procedure (Day of surgery)
Time to Return to Normal Daily Activities	The total number of days taken by the patient to independently resume their baseline activities of daily living and return to light work/routine post-surgery.	Up to 4 months post-operatively

Collaborators and Investigators

• Sponsor: Sohag University

Study record dates

Study Major Dates

• Study Start (Actual): April 1, 2026
• Primary Completion (Estimated): July 1, 2026
• Study Completion (Estimated): July 1, 2026

Study Registration Dates

• First Submitted: May 20, 2026
• First Submitted That Met QC Criteria: May 20, 2026
• First Posted (Actual): May 27, 2026

Study Record Updates

• Last Update Posted (Actual): June 1, 2026
• Last Update Submitted That Met QC Criteria: May 27, 2026
• Last Verified: May 1, 2026

More Information

Terms related to this study

• Keywords: Tapp repair; Recurrant inguinal hernia
• Additional Relevant MeSH Terms: Biological Phenomena; Regeneration; Wound Healing; tetra-4-amidinophenoxypropane
• Other Study ID Numbers: Soh-Med-26-5-3MS

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No